Free Trial

Jasper Therapeutics (JSPR) Earnings Date, Estimates & Call Transcripts

Jasper Therapeutics logo
$4.92 +0.10 (+1.97%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Jasper Therapeutics Earnings Summary

Jasper Therapeutics issued Q1 2025 earnings on May 12, 2025, reporting an EPS of -$1.41, which missed the consensus estimate of -$1.17 by $0.24. With a trailing EPS of -$5.24, Jasper Therapeutics' earnings are expected to decrease next year, from ($4.47) to ($4.62) per share.

Latest Q1
Earnings Date
May. 12Estimated
Consensus EPS
(May. 12)
-$1.17
Actual EPS
(May. 12)
-$1.41 Missed By -$0.24

Q1 2025 Earnings Resources

Get Jasper Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jasper Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

JSPR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Jasper Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$1.48-$0.91-$1.20
Q2 20252-$1.53-$1.37-$1.45
Q3 20252-$1.74-$1.34-$1.54
Q4 20252-$1.95-$1.46-$1.71
FY 2025 8 -$6.70 -$5.08 -$5.89
Q1 20261-$1.52-$1.52-$1.52
Q2 20261-$1.58-$1.58-$1.58
Q3 20261-$1.62-$1.62-$1.62
Q4 20261-$1.66-$1.66-$1.66

Jasper Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025-$1.17-$1.41 -$0.24-$1.41--
2/27/2025Q4 2024-$1.27-$1.62 -$0.35-$1.62--
11/7/2024--$1.09-$1.24 -$0.15-$1.24--
8/13/2024--$1.09-$0.97+$0.12-$0.97--
5/14/2024Q1 2024-$1.26-$1.03+$0.23-$1.03--
3/4/2024Q4 2023-$1.65-$1.50+$0.15-$1.50--
11/9/2023Q3 2023-$1.50-$1.60 -$0.10-$0.16--
8/11/2023Q2 2023-$1.30-$1.50 -$0.20-$0.15--

Jasper Therapeutics Earnings - Frequently Asked Questions

Jasper Therapeutics (NASDAQ:JSPR) last announced its quarterly earning data on Monday, May 12, 2025. Learn more on JSPR's earnings history.

In the previous quarter, Jasper Therapeutics (NASDAQ:JSPR) missed the analysts' consensus estimate of ($1.17) by $0.24 with a reported earnings per share (EPS) of ($1.41). Learn more on analysts' earnings estimate vs. JSPR's actual earnings.

Jasper Therapeutics (NASDAQ:JSPR) has a recorded net income of -$64.46 million. JSPR has generated -$5.24 earnings per share over the last four quarters.

Jasper Therapeutics's earnings are expected to decrease from ($4.47) per share to ($4.62) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:JSPR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners